Artemis Medicare Services Limited has completed the allotment of equity shares under its employee stock option scheme, marking another step in its capital structure evolution. The healthcare company announced the allotment of shares to grantees who exercised their vested options under the established stock option plan.

Share Allotment Details

The company has allotted 1,05,750 equity shares under its Management Stock Option Plan-2021. These shares have been issued as fully paid-up equity shares with a face value of ₹1 each.

Impact on Share Capital

The allotment has resulted in an increase in the company's issued and paid-up equity share capital. The capital structure change reflects the exercise of vested options by eligible grantees under the stock option plan.

Share Characteristics

The newly allotted equity shares carry identical rights and privileges as existing equity shares of the company. They will rank pari-passu with the existing equity shares of the company.

Regulatory Compliance

The company has fulfilled its disclosure obligations regarding the allotment of shares under its employee stock option scheme. This action aligns with Artemis Medicare Services' commitment to employee participation in equity ownership while maintaining compliance with regulatory frameworks governing employee stock option schemes in the healthcare sector.

Artemis Medicare Services Limited , a leading healthcare provider, has reported robust financial performance for the second quarter of fiscal year 2026, alongside announcing significant expansion plans that promise to reshape its market presence.

Strong Financial Performance

The company delivered a consolidated revenue of INR 274.70 crores in Q2 FY26, marking a 13.8% year-on-year growth. This impressive performance was driven by strong showings in key specialties including cardiac sciences, oncology, and neurosciences. The EBITDA margin stood at 21.2%, an improvement from 20.6% in the same quarter last year, indicating enhanced operational efficiency.

Key Financial Highlights

The company's profit after tax before exceptional items reached INR 30.00 crores, showcasing a substantial 35.6% year-on-year increase.

Operational Excellence

Artemis Medicare's flagship facility in Gurugram continued its growth trajectory, supported by an increase in international patients and capacity additions. The hospital reported an occupancy rate of 64.1%, while the Average Revenue Per Occupied Bed (ARPOB) reached INR 81,248, reflecting an improved case mix and a higher proportion of complex procedures.

Notably, the international business contributed approximately 32% of revenues, underlining the company's strong position in the medical value travel segment.

Expansion Plans

The company has outlined an expansion strategy:

1. Raipur Facility: A 300-bed hospital is on track for commissioning by March 2026.
2. South Delhi Project: A binding MoU has been signed for a 650-bed facility in South Delhi.
3. Gurgaon Expansion: Plans to increase capacity to 850-1,000 beds using additional FAR approvals.

Dr. Devlina Chakravarty, Managing Director of Artemis Medicare, stated, "Our focus remains on operational excellence, clinical depth, and disciplined growth. We are committed to expanding our capacity, improving margins, and driving digital innovation to deliver value to all our stakeholders."

Future Outlook

With these expansion plans, Artemis Medicare is positioned for potential growth in the coming years. The company's strategy of maintaining a strong presence in key specialties, coupled with its focus on the international patient segment, may strengthen its market position in the competitive healthcare market.

As the healthcare landscape continues to evolve, Artemis Medicare's investments in advanced medical technologies and expansion into new geographies are expected to contribute to its long-term value creation for shareholders.